Global Feed Anticoccidials Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Monensin, Salinomycin, Diclazuril, and Narasin

By Livestock;

Poultry, Swine, and Ruminants

By Form;

Dry and Liquid

By Source;

Chemical and Natural

By Mode of Consumption;

Oral and Injection

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn133074065 Published Date: May, 2025 Updated Date: July, 2025

Feed Anticoccidials Market Overview

Feed Anticoccidials Market (USD Million)

Feed Anticoccidials Market was valued at USD 427.54 million in the year 2024. The size of this market is expected to increase to USD 577.93 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.


Global Feed Anticoccidials Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 4.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.4 %
Market Size (2024)USD 427.54 Million
Market Size (2031)USD 577.93 Million
Market ConcentrationHigh
Report Pages314
427.54
2024
577.93
2031

Major Players

  • Elanco Animal Health
  • Huvepharma
  • Phibro Animal Health
  • Ceva Animal Health,
  • Zoetis
  • Impextraco
  • Kemin Industries
  • Merck Animal Health
  • Virbac S.A
  • Zydus Animal Health
  • Bioproperties Pty Ltd
  • Qilu Animal Health Products Co. Ltd.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Feed Anticoccidials Market

Fragmented - Highly competitive market without dominant players


The feed anticoccidials market is gaining traction as livestock producers face rising challenges from coccidiosis outbreaks. This intestinal parasitic disease significantly hampers growth and health, especially in poultry. Currently, over 65% of commercial poultry operations regularly include anticoccidials in feed formulations, showcasing their critical role in disease prevention and livestock management.

Focus on Enhancing Livestock Performance
Producers are prioritizing strategies to boost animal growth efficiency and feed utilization. Incorporating anticoccidials into feed has proven to improve growth performance by more than 30% in broilers, reducing economic losses associated with infections. This contributes to healthier animals and higher returns, making anticoccidials a preferred feed additive for performance optimization.

Growing Use of Preventive Feed Solutions
There is a clear move toward preventive health practices in animal farming, where anticoccidials serve as a frontline defense. More than 50% of commercial coccidiosis control measures now rely on feed-based prophylactic applications. Their widespread use helps prevent outbreaks before they occur, supporting both animal welfare and productivity goals.

Advanced Innovations in Feed Additives
Ongoing innovation in feed technology is reshaping how anticoccidials are delivered. Advanced formulations like encapsulated and slow-release additives now account for around 35% of new product introductions. These innovations not only extend effectiveness but also improve consistency in parasite control, reinforcing their value in modern feed programs.

Restraints

  • Limited Availability of Alternatives
  • Trade Barriers and Export Restrictions
  • Emergence of Antimicrobial Resistance - The rise of antimicrobial resistance (AMR) is a major brake on the feed anticoccidials market. Over-reliance on antimicrobial compounds can allow coccidia and other microbes to evolve defenses, undermining treatment efficacy and creating public-health risks.

    To curb AMR, regulators worldwide are tightening rules on antimicrobial feed additives. Regions like the EU have enacted outright bans on routine usage, forcing producers to re-formulate or reformulate products and pushing up R&D costs.

    Consumer sentiment is shifting just as fast. Shoppers increasingly equate “antimicrobial” with “risk,” prompting retailers to favor suppliers who limit or eliminate such inputs. That skepticism can dampen demand for traditional anticoccidials, especially those sharing modes of action with human medicines.

    The knock-on effect is a surge in interest for non-antimicrobial alternatives—vaccines, probiotics, phytogenics, and novel ionophores—reshaping competitive dynamics and squeezing sales of legacy products. In short, AMR is both a scientific and reputational hurdle the industry must clear.

Opportunities

  • Expansion in Emerging Markets
  • Focus on Natural and Organic Alternatives
  • E-commerce and Digitalization
  • Increased Adoption of Preventive Healthcare - Livestock operations are moving from cure to prevention, creating prime opportunities for the feed anticoccidials sector. Routine inclusion of anticoccidials stops coccidiosis outbreaks before they start, avoiding costly treatment, carcass downgrades, and production downtime.

    Preventive healthcare is especially attractive in high-density, vertically integrated systems, where even a 1% uptick in feed conversion ratio (FCR) or survival rate can add millions to annual profit. Anticoccidials deliver that edge without triggering withdrawal periods that disrupt market schedules.

    The trend is reinforced by better digital animal-health monitoring—sensors, AI-driven analytics, and mobile vet support—allowing farms to dose accurately and demonstrate compliance. This precise usage supports both performance and sustainability narratives.

    As sustainability reporting becomes the norm, investors and food brands reward producers who showcase robust, preventative health programs. That alignment of economic, environmental, and social goals positions innovative anticoccidial formulations as a cornerstone of next-generation livestock management..

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Livestock
    3. Market Snapshot, By Form
    4. Market Snapshot, By Source
    5. Market Snapshot, By Mode Of Consumption
    6. Market Snapshot, By Region
  4. Feed Anticoccidials Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Intensification of Livestock Production

        2. Technological Advancements

        3. Focus on Animal Health and Welfare

        Restraints
        1. Limited Availability of Alternatives

        2. Trade Barriers and Export Restrictions

        3. Emergence of Antimicrobial Resistance

      2. Opportunities
        1. Expansion in Emerging Markets

        2. Focus on Natural and Organic Alternatives

        3. E-commerce and Digitalization

        4. Increased Adoption of Preventive Healthcare

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Feed Anticoccidials Market, By Type, 2021 - 2031 (USD Million)
      1. Monensin
      2. Salinomycin
      3. Diclazuril
      4. Narasin
    2. Feed Anticoccidials Market, By Livestock, 2021 - 2031 (USD Million)
      1. Poultry
      2. Swine
      3. Ruminants
    3. Feed Anticoccidials Market, By Form, 2021 - 2031 (USD Million)
      1. Dry
      2. Liquid
    4. Feed Anticoccidials Market, By Source, 2021 - 2031 (USD Million)
      1. Natural
      2. Chemical
    5. Feed Anticoccidials Market, By Mode Of Consumption, 2021 - 2031 (USD Million)
      1. Oral
      2. Injection
    6. Feed Anticoccidials Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. Canada
        2. United States
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Elanco Animal Health
      2. Huvepharma
      3. Phibro Animal Health
      4. Ceva Animal Health
      5. Zoetis
      6. Impextraco
      7. Kemin Industries
      8. Merck Animal Health
      9. Virbac S.A
      10. Zydus Animal Health
      11. Bioproperties Pty Ltd
      12. Qilu Animal Health Products Co. Ltd.
  7. Analyst Views
  8. Future Outlook of the Market